IU Philanthropic Fund invests in Carmel pharmaceutical company

In an effort to treat Autism and Fragile X Syndrome, the IU Philanthropic Fund has made a $100,000 bridge investment in Carmel-based Confluence Pharmaceuticals. The new investment adds to the initial $200,000 from the fund in November 2018 as the company prepares for Phase II clinical trials and a Series B funding round next year.